Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Gastrointestinal 7Genitourinary 4Other 3Thoracic 2Other solid neoplasm 2Gynecologic 2Plasma cell 1Other neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Overweight 1Ovarian Neoplasms 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 92Cisplatin 67Specimen Handling 63Magnetic Resonance Spectroscopy 52olaparib 51Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Doxorubicin 26Topotecan 25Letrozole 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21durvalumab 20Surveys and Questionnaires 20Disulfides 20dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nutrition Assessment × Gynecologic × 1 year × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT01439659 2026-01-16

Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡